Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Marevan
Active Ingredient: Warfarin sodium 1mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturer: Douglas Manufacturing Limited, Auckland, New Zealand
   
Product: Marevan
Active Ingredient: Warfarin sodium 3mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturer: Douglas Manufacturing Limited, Auckland, New Zealand
   
Product: Marevan
Active Ingredient: Warfarin sodium 5mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturer: Douglas Manufacturing Limited, Auckland, New Zealand
   
Product: Zavicefta
Active Ingredients: Avibactam sodium 543.5mg equivalent to avibactam 500mg
Ceftazidime pentahydrate 2329.7mg equivalent to ceftazidime 2000mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: ACS Dobfar SpA, Verona, Italy


Dated this 14th day of October 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).